Monte Carlo simulation analysis of ceftobiprole, dalbavancin, daptomycin, tigecycline, linezolid and vancomycin pharmacodynamics against intensive care unit-isolated methicillin-resistantStaphylococcus aureus-Reference-Cited by-同舟云学术

Monte Carlo simulation analysis of ceftobiprole, dalbavancin, daptomycin, tigecycline, linezolid and vancomycin pharmacodynamics against intensive care unit-isolated methicillin-resistantStaphylococcus aureus

Published:2014-05-20 Issue:6 Volume:41 Page:437-443
ISSN:0305-1870
Container-title:Clinical and Experimental Pharmacology and Physiology
language:en
Short-container-title:Clin Exp Pharmacol Physiol

Author:

Salem Ahmed Hamed¹²,Zhanel George G³,Ibrahim Safaa A⁴⁵,Noreddin Ayman M⁶⁷

Affiliation:

1. Department of Experimental and Clinical Pharmacology; College of Pharmacy; University of Minnesota; Minneapolis MN USA

2. Department of Clinical Pharmacy; Faculty of Pharmacy; Ain Shams University; Cairo Egypt

3. Department of Medical Microbiology; University of Manitoba; Winnipeg MB Canada

4. Department of Microbiology and Immunology; Chicago Medical School; Rosalind Franklin University of Medicine and Science; North Chicago IL USA

5. Department of Microbiology and Immunology; Cairo University; Cairo Egypt

6. Department of Pharmacy Practice; School of Pharmacy; Hampton University; Hampton VA USA

7. Biomedical Sciences Graduate Program; Eastern Virginia Medical School; Norfolk VA USA

Publisher

Wiley

Subject

Physiology (medical),Pharmacology,Physiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/1440-1681.12195/fullpdf

Reference61 articles.

1. Antimicrobial resistance among gram-positive organisms in the intensive care unit;Clark;Curr. Opin. Crit. Care,2003

2. The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges;Cosgrove;Infect. Control Hosp. Epidemiol.,2005

3. Celbenin-resistant staphylococci;Jevons;Br. Med. J.,1961

4. Emergence of methicillin-resistant Staphylococcus aureus with intermediate glycopeptide resistance: clinical significance and treatment options;Rybak;Drugs,2001

5. Methicillin-resistant Staphylococcus aureus infections in ICU patients;Sista;Anesthesiol. Clin. North Am.,2004

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-life experience with IV dalbavancin in Canada; results from the CLEAR (Canadian LEadership on Antimicrobial Real-life usage) registry;Journal of Global Antimicrobial Resistance;2024-09

2. How is ceftobiprole used in Canada: the CLEAR study final results;Expert Review of Anti-infective Therapy;2024-07-15

3. Hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP) in Canada: treatment update and the role of new IV antimicrobials;Expert Review of Anti-infective Therapy;2023-10-13

4. Optimal drug therapy for Staphylococcus aureus bacteraemia in adults;Current Opinion in Critical Care;2023-07-27

5. Assessing Clinical Potential of Old Antibiotics against Severe Infections by Multi-Drug-Resistant Gram-Negative Bacteria Using In Silico Modelling;Pharmaceuticals;2022-11-30